COVO-Iran Barakat vaccine

Alborz (IP): The first product of mass production of the Iranian COVID-19 vaccine called COVO-Iran Barakat will be unveiled on Tuesday, in the presence of the Health Minister.

Iran PressIran news: The first product of mass production of Iranian  COVID-19 vaccine called COVO-Iran Barakat in phase one of the its production in one of the factories of Execution of Imam Khomeini's Order, Tuesday, in the presence of Saeed Namaki, Minister of Health, Treatment, and Medical Education, the Iranian medicine is scheduled to be unveiled in Alborz province.

Reza Mazhari, the executive director of the "COVO-Iran Barakat" vaccine project, said: "After passing the semi-industrial phase, we entered the mass production phase of the vaccine and decided to prepare two industrial lines, the first production line being prepared and the second is under construction."

Reza Mazhari added: "With the launch of these two production lines until September 22, 2021 (end of Shahrivar this year 1400), taking into account the capacity of three million doses of the first line, 20 million doses of "COVO-Iran Barakat" vaccine will be available per month.

Human injection of the first phase of clinical studies of the first COVID-19 vaccine made by Iranian researchers called COVO-Iran Barakat began on December 29, 2020.

214/203

Read more: 

Results of 1st phase of COVIran Barekat vaccine announced

COV Iran Barakat" vaccine is ready to enter the second stage of human trial